JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies

JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies

The use of a highly-effective treatment for multiple sclerosis (MS) is associated with a severe risk of developing complications, such as progressive multifocal leukoencephalopathy (PML) caused by the John Cunningham virus (JCV). The aim of this study was to evaluate the correlation between anti-JCV...

Full description

Bibliographic Details
Main Authors: Robert Bonek, Wojciech Guenter, Robert Jałowiński, Anna Karbicka, Anna Litwin, Maciej Maciejowski, Radosław Zajdel, Karolina Zajdel, Veronique Petit, Konrad Rejdak
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
multiple sclerosis
John Cunningham virus
anti-JCV antibody
antibody index
disease-modifying therapies
Online Access:https://www.mdpi.com/2077-0383/10/9/1998

Internet

https://www.mdpi.com/2077-0383/10/9/1998

Similar Items